Quince Therapeutics, Inc. Common Stock
QNCXQuince Therapeutics, Inc. (QNCX) is a biotechnology company focused on developing therapies for bone-related disorders. It aims to address unmet medical needs by advancing innovative treatments targeting bone regeneration and repair.
Company News
Quince Therapeutics announced the acquisition of Orphai Therapeutics and secured up to $187 million in private placement financing ($115 million upfront plus up to $72 million from warrant exercises). The acquisition brings LAM-001, an inhaled rapamycin formulation for rare pulmonary diseases including pulmonary hypertension associated with inter...
Quince Therapeutics and XBiotech are included in this Analyst Blog.
Two microcap biotech stocks to consider for the science-challenged among us.
The Dow Jones closed higher by over 60 points on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision. Below is a look at a few recent notable insider tran...
The Dow Jones closed higher by around 300 points on Friday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision. Below is a look at a few recent notable insider tra...
